Soamnauth Misir

Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer

Lori J. Wirth, Marcia S. Brose, Eric J. Sherman et al. · Journal of Clinical Oncology · 2021 · 121 citations · Full text

Medicine, Oncology, Pharmacology +15

Colesevelam Hydrochloride: Efficacy and Safety in Pediatric Subjects with Heterozygous Familial Hypercholesterolemia

Evan A. Stein, A. David Marais, Tamás Szamosi et al. · The Journal of Pediatrics · 2009 · 78 citations

Medicine, Pediatrics, Pharmacology +14

Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma

Angel Alsina, Masatoshi Kudo, Arndt Vogel et al. · Liver Cancer · 2019 · 75 citations · Full text

Medicine, Oncology, Pharmacology +17

Abstract PD6-13: Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer

SM Tolaney, Kevin Kalinsky, Virginia Kaklamani et al. · Cancer Research · 2018 · 71 citations

Medicine, Oncology, Pharmacology +17

The Effect of Colesevelam Hydrochloride on Insulin Sensitivity and Secretion in Patients With Type 2 Diabetes: A Pilot Study

Sherwyn Schwartz, Yu‐Ling Lai, Jianbo Xu et al. · Metabolic Syndrome and Related Disorders · 2010 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16